Literature DB >> 6136647

Cyclosporin improves Graves' ophthalmopathy.

A P Weetman, A M McGregor, M Ludgate, L Beck, P V Mills, J H Lazarus, R Hall.   

Abstract

Cyclosporin given to two patients with Graves' ophthalmopathy produced a rapid objective improvement in both, including restoration of ocular-muscle function and visual acuity, improvement in exophthalmos, and reduction in orbital muscle swelling judged by computed tomographic scan. Thyroid autoantibody levels fell with treatment, and T-cell subset abnormalities returned towards normal. In one patient an absent thyrotropin response to thyrotropin-releasing hormone became normal after treatment. These results suggest that cyclospirin treatment should be considered in patients with the congestive ophthalmopathy of Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136647     DOI: 10.1016/s0140-6736(83)90514-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  Early diagnosis of Graves' optic neuropathy using visual evoked responses.

Authors:  J A Batch; F Lepre
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Ocular manifestations of Graves' disease.

Authors:  W Kelly; R Cove-Smith; A Rashid
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

Review 3.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

4.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

5.  Orbital decompression for severe dysthyroid eye disease.

Authors:  P Fells
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

6.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

Review 7.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

8.  Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.

Authors:  A A Drosos; F N Skopouli; J S Costopoulos; C S Papadimitriou; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

9.  The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat.

Authors:  R A Hassman; C Dieguez; D P Rennie; A P Weetman; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

10.  The use of systemic cyclosporin a in human corneal transplantation: a preliminary report.

Authors:  J C Hill
Journal:  Doc Ophthalmol       Date:  1986-05-15       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.